T Hisamatsu - Sch Med, Kyorin Univ | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 59 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A multicenter retrospective real-world study to determine the optimal cases of vedolizumab-treated UC patients

T. Kobayashi,T. Hisamatsu, K. Ishiguro, L. Hirose, T. Hibi

JOURNAL OF CROHNS & COLITIS (2024): I1670-I1670

引用0浏览0引用

A new criterion, combining bowel wall thickness and submucosal index (SMI), is useful for estimating endoscopic improvement in Ulcerative Colitis

H. Komatsu, H. Morikubo, Y. Kimura, H. Yonezawa, M. Matsuura, J. Miyoshi,T. Hisamatsu

JOURNAL OF CROHNS & COLITIS (2024): I832-I832

引用0浏览0引用

Machine learning to predict the efficacy of ustekinumab for ulcerative colitis

H. Morikubo, R. Tojima, T. Maeda, K. Matsuoka, M. Matsuura,J. Miyoshi, S. Tamura,T. Hisamatsu

JOURNAL OF CROHNS & COLITIS (2024): I1940-I1941

引用0浏览0引用

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety data

K. Matsuoka,S. Motoya, T. Yamamoto, M. Matsuura, T. Fujii,S. Shinzaki, Y. Mikami, S. Arai,J. Oshima, Y. Endo, H. Yuasa, M. Hoshi,

JOURNAL OF CROHNS & COLITIS (2024): I1407-I1409

引用0浏览0引用

Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)

K. Matsuoka, H. Nakase, T. Fujii,T. Hisamatsu, Y. Suzuki, M. Watanabe, Y. Uchikawa, S. Goto, G. Fujimoto, C. Zhang,T. Hibi

JOURNAL OF CROHNS & COLITIS (2024): I1295-I1296

引用0浏览0引用

Efficacy and safety of etrasimod in patients with moderately to severely active UC in Japan: Integrated analysis of the phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN trials

K. Takeuchi,T. Hisamatsu,H. Nakase, K. Matsuoka, M. Keating, H. Yuasa, M. Oe, S. Arai,T. Hibi

JOURNAL OF CROHNS & COLITIS (2024): I644-I645

引用0浏览0引用

Clinical features and surgical necessity rate of fistulising perianal disease in newly diagnosed patients with Crohn's disease: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD)

N. Takatsu, T. Yamamoto,H. Nakase,S. Shinzaki,K. Watanabe, T. Fujii,R. Okamoto,K. Matsuoka,A. Yamada,R. Kunisaki,M. Matsuura, H. Shiga,

JOURNAL OF CROHNS & COLITIS (2024): I2104-I2106

引用0浏览0引用

Early sonographic improvement predicts the middle-term efficacy of molecular-targeted medications for Ulcerative Colitis

J. Miyoshi, Y. Kimura, H. Morikubo, H. Komatsu, H. Yonezawa, M. Matsuura,T. Hisamatsu

JOURNAL OF CROHNS & COLITIS (2024): I659-I659

引用0浏览0引用

P193 Predicting the middle-term efficacy of molecular-targeted medications for Ulcerative Colitis based on the intestinal ultrasound findings

J Miyoshi, H Morikubo, H Yonezawa, Y Kimura, C Moue, H Komatsu, M Matsuura,T Hisamatsu

Journal of Crohn's and Colitisno. Supplement_1 (2023): I346-I347

引用0浏览0引用

P094 Impacts of 5-aminosalicylic acid on the intestinal microbiota leading to the anti-inflammatory effect

H Wada,J Miyoshi, S Kuronuma, N Hibi, Y Nishinarita, N Oguri, M Matsuura,O Takeuchi, T Kobayashi, Y Akimoto,T Hibi,T Hisamatsu

Journal of Crohn's and Colitis（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn